Skip to main content


Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Good calls: Vertex, InterMune, Chelsea, Galena, Exact Sciences. The bad calls: Avanir, Amarin, Exelixis and the bursting biotech stock bubble.

Jim Cramer on the Stock Market: You Have to Love Biotech

In this era of turmoil, investors can take comfort in this sector.

Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs

Oil prices backtrack from Monday's bounce, but energy stocks shake it off. Instead, the sector gains more than 1% after several weeks of punishing losses.

Stocks Hover Near Highs as Oil Backtracks From Monday Bounce

Oil is back in the spotlight Tuesday as prices backtrack from Monday's bounce and move lower again.

Stocks Gain as Construction Spending Expands, Global Stimulus Talk Heats Up

U.S. stocks book modest gains on Tuesday morning as domestic construction spending expands.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.